GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pharmacom Biovet PHMB · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2003

Net income

−$160,000

FY2003FY2003

Free cash flow

−$47.16bn

FY2003FY2003

Shareholders' equity

$114,000

FY2003FY2003

Income statement

Fiscal years

FY2003
Operating income−$160,000
Net income−$160,000
Diluted earnings per share-0.28

Balance sheet

At each fiscal year end

FY2003
Total assets$163,000
Total liabilities$48,000
Shareholders' equity$114,000
Shares outstanding1m

Cash flow

Fiscal years

FY2003
Capital spending−$47.16bn
Free cash flow−$47.16bn
Dividends paid−$101.75bn

Latest quarters

By quarter end

Sept 2004Jun 2004Mar 2004Dec 2003Jun 2003Mar 2003Dec 2002Sept 2002
Operating income−$171,000−$342,000−$339,000−$20,000−$40,000−$103,600−$215,330−$21,850
Net income−$296,000−$342,000−$339,000−$20,000−$40,000−$103,600−$215,330−$21,850
Diluted earnings per share-0.20-0.34-0.41-0.03-0.06-0.17-0.98-0.10
Total assets$5,000$130,000$130,000$163,000$160,000$162,963$112,363$4,500
Debt———————$1,075
Shareholders' equity−$56,000$67,000$81,000$114,000$130,000$134,425$50,825−$4,575

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-79.4%175.9%—
Net income-79.4%175.9%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%0%4344%300%900%100%100%0%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 15-to-1 reverse split · 10 Sept 2008
  • 6-to-1 reverse split · 15 Sept 2004

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.